Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.64
7.61
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Shandong Weigao Group Medical Polymer Co Ltd stock under the Base Case scenario is 9 HKD. Compared to the current market price of 4.4 HKD, Shandong Weigao Group Medical Polymer Co Ltd is Undervalued by 51%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Shandong Weigao Group Medical Polymer Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Shandong Weigao Group Medical Polymer Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Shandong Weigao Group Medical Polymer Co Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Shandong Weigao Group Medical Polymer Co Ltd
Balance Sheet Decomposition
Shandong Weigao Group Medical Polymer Co Ltd
Current Assets | 19.5B |
Cash & Short-Term Investments | 7.9B |
Receivables | 8B |
Other Current Assets | 3.7B |
Non-Current Assets | 15B |
Long-Term Investments | 2.1B |
PP&E | 7.3B |
Intangibles | 5.1B |
Other Non-Current Assets | 474.4m |
Current Liabilities | 6B |
Accounts Payable | 4.7B |
Other Current Liabilities | 1.2B |
Non-Current Liabilities | 5.5B |
Long-Term Debt | 3.5B |
Other Non-Current Liabilities | 2.1B |
Earnings Waterfall
Shandong Weigao Group Medical Polymer Co Ltd
Revenue
|
13B
CNY
|
Cost of Revenue
|
-6.5B
CNY
|
Gross Profit
|
6.5B
CNY
|
Operating Expenses
|
-4B
CNY
|
Operating Income
|
2.5B
CNY
|
Other Expenses
|
-557.2m
CNY
|
Net Income
|
1.9B
CNY
|
Free Cash Flow Analysis
Shandong Weigao Group Medical Polymer Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Shandong Weigao Group Medical Polymer Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Shandong Weigao Group Medical Polymer Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shandong Weigao Group Medical Polymer Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Shandong Weigao Group Medical Polymer Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shandong Weigao Group Medical Polymer Co Ltd
According to Wall Street analysts, the average 1-year price target for Shandong Weigao Group Medical Polymer Co Ltd is 6.79 HKD with a low forecast of 5.15 HKD and a high forecast of 8.4 HKD.
Dividends
Current shareholder yield for Shandong Weigao Group Medical Polymer Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Weihai, Shandong. The company went IPO on 2004-02-27. The firm sells products under brand names of Jierui and Wego Ortho. The firm operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The firm is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
Contact
IPO
Employees
Officers
The intrinsic value of one Shandong Weigao Group Medical Polymer Co Ltd stock under the Base Case scenario is 9 HKD.
Compared to the current market price of 4.4 HKD, Shandong Weigao Group Medical Polymer Co Ltd is Undervalued by 51%.